Zfp599 inhibitors refer to a class of chemical compounds that specifically target and inhibit the activity of Zfp599, a zinc finger protein belonging to the large family of transcription factors. Zinc finger proteins, including Zfp599, are characterized by their zinc-coordinated motifs that bind to DNA and influence gene expression. These proteins play a pivotal role in the regulation of cellular processes by modulating the transcription of various genes. The inhibition of Zfp599 can lead to the alteration of gene regulatory networks, affecting the transcriptional landscape of the cell. Zfp599 itself contains multiple zinc finger domains, which facilitate its interaction with specific DNA sequences, typically in the promoter regions of genes. By inhibiting the protein's function, Zfp599 inhibitors effectively block its ability to bind to DNA, thereby influencing downstream gene expression patterns.
The design and development of Zfp599 inhibitors require a deep understanding of the protein's structure, particularly its zinc finger motifs, as these domains are responsible for both DNA recognition and binding. Researchers often focus on identifying compounds that can interfere with these critical domains, either by chelating the zinc ions or by binding to the protein in a way that disrupts its ability to interact with DNA. Additionally, some inhibitors may be designed to disrupt the protein-protein interactions that are crucial for the regulatory functions of Zfp599. The specificity of these inhibitors is of particular interest, as zinc finger proteins are highly diverse, and achieving selectivity for Zfp599 without affecting other similar transcription factors is a challenge. The impact of these inhibitors on cellular pathways can be broad, affecting gene expression profiles and leading to insights into the roles of Zfp599 in biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1 which is involved in the MAPK/ERK pathway. Zinc finger protein 599, through its role in DNA binding and transcription, could be regulated by ERK signaling, and inhibition of MEK1 by PD98059 leads to decreased ERK activity and thus inhibition of zinc finger protein 599 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that prevents the activation of MAPK/ERK pathway. By inhibiting MEK, U0126 reduces the activity of ERK2 which in turn inhibits the transcriptional regulatory activity of zinc finger protein 599. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which suppresses the PI3K/Akt signaling pathway. Given that zinc finger protein 599 activity can be modulated by Akt-mediated signaling, inhibition of PI3K by LY294002 leads to a decrease in zinc finger protein 599 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is also a PI3K inhibitor. By inhibiting PI3K, it prevents Akt phosphorylation and activation. This results in the inhibition of downstream signaling pathways that could control the functional activity of zinc finger protein 599. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin selectively inhibits mTOR, which is part of the PI3K/Akt pathway. The inhibition of mTOR can decrease the activity of certain transcription factors that may be necessary for the full functional activity of zinc finger protein 599. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. By inhibiting p38, it disrupts the signaling that may be necessary for the regulation of zinc finger protein 599, leading to an inhibition of its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathway. Inhibition of JNK can alter the transcriptional regulation by zinc finger protein 599 by affecting its associated signaling pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases can phosphorylate various proteins involved in signaling pathways that regulate the activity of proteins like zinc finger protein 599, thus its inhibition can lead to decreased zinc finger protein 599 activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib inhibits multiple tyrosine kinases including Src family kinases. This inhibition can disrupt signaling pathways that indirectly regulate the activity of zinc finger protein 599, leading to its functional inhibition. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK which is involved in actin cytoskeleton arrangement. Disruption of the actin cytoskeleton can affect cellular processes that may indirectly inhibit the function of zinc finger protein 599. | ||||||